Perspective Therapeutics, Inc.
CATXNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for CATX. That does not mean none is planned.
Get an email about CATX's next catalysts
Track Perspective Therapeutics (CATX) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 1 past
No catalysts found.
Market Overview
Stock performance and key metrics
[203Pb]VMT-α-NET
Neuroendocrine Tumors Unresectable
[203Pb]VMT01
Recurrent Melanoma (Skin)
[203Pb]Pb-PSV359
Pancreatic Ductal Adenocarcinoma
[212Pb]Pb-PSV359
Pancreatic Ductal Adenocarcinoma
[212Pb]VMT01
Recurrent Melanoma (Skin)
[212Pb]VMT-α-NET
Neuroendocrine Tumors Unresectable
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
[203Pb]VMT-α-NET | Phase 2 | Neuroendocrine Tumors Unresectable | - | - |
[203Pb]VMT01 | Phase 2 | Recurrent Melanoma (Skin) | - | - |
[203Pb]Pb-PSV359 | Phase 2 | Pancreatic Ductal Adenocarcinoma | - | - |
[212Pb]Pb-PSV359 | Phase 2 | Pancreatic Ductal Adenocarcinoma | - | - |
[212Pb]VMT01 | Phase 2 | Recurrent Melanoma (Skin) | - | - |
[212Pb]VMT-α-NET | Phase 2 | Neuroendocrine Tumors Unresectable | - | - |
Advanced melanoma
2 drugs in this indication
Advanced SSTR2-expressing neuroendocrine tumors (NETs)
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Perspective Therapeutics, Inc.'s drug pipeline?→
CatalystAlert tracks 6 drug candidates in Perspective Therapeutics, Inc.'s (CATX) pipeline across Phase 2. Its lead program is [203Pb]Pb-PSV359 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Perspective Therapeutics, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Perspective Therapeutics, Inc. (CATX) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track CATX biotech catalysts?→
Add CATX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Perspective Therapeutics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.
